358 related articles for article (PubMed ID: 20455701)
21. Physiologic and rheologic effects of the antisickling agent ethacrynic acid and its N-butylated derivative on normal and sickle erythrocytes.
Orringer EP; Blythe DS; Whitney JA; Brockenbrough S; Abraham DJ
Am J Hematol; 1992 Jan; 39(1):39-44. PubMed ID: 1536139
[TBL] [Abstract][Full Text] [Related]
22. Extracellular fluid tonicity impacts sickle red blood cell deformability and adhesion.
Carden MA; Fay ME; Lu X; Mannino RG; Sakurai Y; Ciciliano JC; Hansen CE; Chonat S; Joiner CH; Wood DK; Lam WA
Blood; 2017 Dec; 130(24):2654-2663. PubMed ID: 28978568
[TBL] [Abstract][Full Text] [Related]
23. The clinical pathophysiology of sickle cell disease.
Embury SH
Annu Rev Med; 1986; 37():361-76. PubMed ID: 2423018
[TBL] [Abstract][Full Text] [Related]
24. Concurrent sickle cell anemia and alpha-thalassemia. Effect on pathological properties of sickle erythrocytes.
Embury SH; Clark MR; Monroy G; Mohandas N
J Clin Invest; 1984 Jan; 73(1):116-23. PubMed ID: 6690472
[TBL] [Abstract][Full Text] [Related]
25. Abnormal permeability pathways in human red blood cells.
Ellory JC; Robinson HC; Browning JA; Stewart GW; Gehl KA; Gibson JS
Blood Cells Mol Dis; 2007; 39(1):1-6. PubMed ID: 17434766
[TBL] [Abstract][Full Text] [Related]
26. In vitro exposure to hydroxyurea reduces sickle red blood cell deformability.
Huang Z; Louderback JG; King SB; Ballas SK; Kim-Shapiro DB
Am J Hematol; 2001 Jul; 67(3):151-6. PubMed ID: 11391710
[TBL] [Abstract][Full Text] [Related]
27. Red blood cell membrane and density changes under ambient and hypoxic conditions in transgenic mice producing human sickle hemoglobin.
Reilly MP; Chomo MJ; Obata K; Asakura T
Exp Hematol; 1994 Jun; 22(6):501-9. PubMed ID: 8187846
[TBL] [Abstract][Full Text] [Related]
28. Erythrocyte heterogeneity in sickle cell disease: effect of deoxygenation on intracellular polymer formation and rheology of sub-populations.
Keidan AJ; Noguchi CT; Player M; Chalder SM; Stuart J
Br J Haematol; 1989 Jun; 72(2):254-9. PubMed ID: 2757967
[TBL] [Abstract][Full Text] [Related]
29. Sickle cell anemia as a rheologic disease.
Horne MK
Am J Med; 1981 Feb; 70(2):288-98. PubMed ID: 7008586
[TBL] [Abstract][Full Text] [Related]
30. Flow dynamics of human sickle erythrocytes in the mesenteric microcirculation of the exchange-transfused rat.
Kurantsin-Mills J; Jacobs HM; Klug PP; Lessin LS
Microvasc Res; 1987 Sep; 34(2):152-67. PubMed ID: 3670112
[TBL] [Abstract][Full Text] [Related]
31. Rate of deoxygenation modulates rheologic behavior of sickle red blood cells at a given mean corpuscular hemoglobin concentration.
Kaul DK; Liu XD
Clin Hemorheol Microcirc; 1999; 21(2):125-35. PubMed ID: 10599596
[TBL] [Abstract][Full Text] [Related]
32.
Qiang Y; Liu J; Dao M; Du E
Lab Chip; 2021 Sep; 21(18):3458-3470. PubMed ID: 34378625
[TBL] [Abstract][Full Text] [Related]
33. Pfaffia paniculata extract improves red blood cell deformability in sickle cell patients.
Mozar A; Charlot K; Sandor B; Rabaï M; Lemonne N; Billaud M; Hardy-Dessources MD; Beltan E; Pandey RC; Connes P; Ballas SK
Clin Hemorheol Microcirc; 2015 Sep; 62(4):327-33. PubMed ID: 26444603
[TBL] [Abstract][Full Text] [Related]
34. Red blood cells modulate structure and dynamics of venous clot formation in sickle cell disease.
Faes C; Ilich A; Sotiaux A; Sparkenbaugh EM; Henderson MW; Buczek L; Beckman JD; Ellsworth P; Noubouossie DF; Bhoopat L; Piegore M; Renoux C; Bergmeier W; Park Y; Ataga KI; Cooley B; Wolberg AS; Key NS; Pawlinski R
Blood; 2019 Jun; 133(23):2529-2541. PubMed ID: 30952675
[TBL] [Abstract][Full Text] [Related]
35. Importance of methodological standardization for the ektacytometric measures of red blood cell deformability in sickle cell anemia.
Renoux C; Parrow N; Faes C; Joly P; Hardeman M; Tisdale J; Levine M; Garnier N; Bertrand Y; Kebaili K; Cuzzubbo D; Cannas G; Martin C; Connes P
Clin Hemorheol Microcirc; 2016; 62(2):173-9. PubMed ID: 26444610
[TBL] [Abstract][Full Text] [Related]
36. Static and dynamic rigidities of normal and sickle erythrocytes. Major influence of cell hemoglobin concentration.
Evans E; Mohandas N; Leung A
J Clin Invest; 1984 Feb; 73(2):477-88. PubMed ID: 6699172
[TBL] [Abstract][Full Text] [Related]
37. GBT021601 improves red blood cell health and the pathophysiology of sickle cell disease in a murine model.
Dufu K; Alt C; Strutt S; Partridge J; Tang T; Siu V; Liao-Zou H; Rademacher P; Williams AT; Muller CR; Geng X; Pochron MP; Dang AN; Cabrales P; Li Z; Oksenberg D; Cathers BE
Br J Haematol; 2023 Jul; 202(1):173-183. PubMed ID: 36960712
[TBL] [Abstract][Full Text] [Related]
38. Evolving treatment paradigms in sickle cell disease.
Jagadeeswaran R; Rivers A
Hematology Am Soc Hematol Educ Program; 2017 Dec; 2017(1):440-446. PubMed ID: 29222291
[TBL] [Abstract][Full Text] [Related]
39. Electrical Impedance Characterization of Erythrocyte Response to Cyclic Hypoxia in Sickle Cell Disease.
Liu J; Qiang Y; Alvarez O; Du E
ACS Sens; 2019 Jul; 4(7):1783-1790. PubMed ID: 31083931
[TBL] [Abstract][Full Text] [Related]
40. 2015 Clinical trials update in sickle cell anemia.
Archer N; Galacteros F; Brugnara C
Am J Hematol; 2015 Oct; 90(10):934-50. PubMed ID: 26178236
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
